Upvote
Downvote
Associate Director, Manufacturing
Share Job
- Suggest Revision
Full-time
- Corcept is leading the way in the research and development of cortisol modulators, molecules that regulate cortisol activity at the glucocorticoid receptor (GR).
- In 2012, we received FDA approval of Korlym (mifepristone), the first approved treatment for hypercortisolism (Cushing syndrome).
- With more than 30 ongoing studies across a wide range of disease areas, including endocrinology, oncology, metabolism, and neurology, we remain dedicated to advance the possibilities of cortisol modulation.
- What began as a ripple of scientific truth is now poised to unleash a sea change of discovery representing a fundamental shift in the way we understand and treat disease.
- Responsibilities include managing CMO business relationships, overseeing development and production activities of Drug Product at CMOs, and providing technical support and troubleshooting, as well as authoring CMC sections of regulatory filings.
Active Job
Updated TodaySimilar Job
Relevance
Active